+Compare
ICPT
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
794.69M

ICPT Intercept Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of therapeutics for the treatment of chronic fibrotic and metabolic diseases

Industry Biotechnology
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sorrento Therapeutics, Inc. (OTC:SRNEQ).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.28B. The market cap for tickers in the group ranges from 402 to 464.61B. NVO holds the highest valuation in this group at 464.61B. The lowest valued company is PNEXF at 402.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 5%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 24%. SGMT experienced the highest price growth at 133%, while SRNEQ experienced the biggest fall at -75%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 3%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was 49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 55
SMR Rating: 94
Profit Risk Rating: 93
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

ICPT is expected to report earnings to rise 61.57% to -22 cents per share on November 14

Intercept Pharmaceuticals ICPT Stock Earnings Reports
Q3'23
Est.
$-0.23
Q2'23
Beat
by $0.37
Q1'23
Missed
by $0.14
Q4'22
Missed
by $0.07
Q3'22
Missed
by $2.22
The last earnings report on August 02 showed earnings per share of -14 cents, beating the estimate of -50 cents. With 3.91M shares outstanding, the current market capitalization sits at 794.69M.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for the treatment of chronic fibrotic and metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
305 Madison Avenue
Phone
+1 646 747-1000
Employees
341
Web
https://www.interceptpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFNTX12.32N/A
N/A
Fidelity Advisor Asset Manager 40% M
SEWIX15.35-0.01
-0.07%
Guggenheim World Equity Income I
DLHIX25.61-0.14
-0.54%
Delaware Healthcare I
MCVIX30.18-0.19
-0.63%
MFS Mid Cap Value I
FHETX15.92-0.23
-1.42%
Fidelity Advisor Real Estate M

ICPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICPT has been loosely correlated with TRML. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ICPT jumps, then TRML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICPT
1D Price
Change %
ICPT100%
N/A
TRML - ICPT
59%
Loosely correlated
-6.37%
TPST - ICPT
58%
Loosely correlated
-0.51%
SLNO - ICPT
57%
Loosely correlated
-3.66%
CLLS - ICPT
55%
Loosely correlated
-2.08%
KRRO - ICPT
55%
Loosely correlated
+20.24%
More

Groups containing ICPT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICPT
1D Price
Change %
ICPT100%
N/A
challenging disorders
(undefined stocks)
17%
Poorly correlated
+0.60%
treatment
(undefined stocks)
13%
Poorly correlated
+2.89%
metabolic
(undefined stocks)
10%
Poorly correlated
+2.48%
pharmaceuticals
(undefined stocks)
4%
Poorly correlated
+0.61%
therapeutics
(undefined stocks)
4%
Poorly correlated
+0.80%